Literature DB >> 15275280

Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas.

J P Chippaux1, M Boussinesq, J Gardon, N Gardon-Wendel, J C Ernould.   

Abstract

The control of onchocerciasis remains a priority in sub-Saharan Africa. Jean-Philippe Chippaux, Michel Boussinesq, Jacques Gardon, Nathalie Gardon-Wendel and Jean-Christophe Ernould here outline studies concerning possible severe adverse reactions to ivermectin used to control onchocerciasis in areas where loiasis is also endemic, and discuss precautions that may be advisable during the implementation of such programmes.

Entities:  

Year:  1996        PMID： 15275280     DOI： 10.1016/0169-4758(96)40006-0

Source DB:  PubMed          Journal:  Parasitol Today        ISSN： 0169-4758


  49 in total

Review 1.  Mining Filarial Genomes for Diagnostic and Therapeutic Targets.

Authors:  Sasisekhar Bennuru; Elise M O'Connell; Papa M Drame; Thomas B Nutman
Journal:  Trends Parasitol       Date:  2017-10-12

2.  In vitro activities of plant extracts on human Loa loa isolates and cytotoxicity for eukaryotic cells.

Authors:  Line-Edwige Mengome; Jean Paul Akue; Alain Souza; Guy Raymond Feuya Tchoua; Edouard Nsi Emvo
Journal:  Parasitol Res       Date:  2010-05-22       Impact factor: 2.289

3.  A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.

Authors:  Fanny Legrand; Jesica Herrick; Michelle Makiya; Roshan Ramanathan; Reagan Thompson; Shakuntala Rampertaap; Jennifer Stoddard; JeanAnne Ware; Michael P Fay; Nicole Holland-Thomas; Thomas B Nutman; Amy D Klion
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

4.  Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon.

Authors:  Samuel Wanji; Nicholas Tendongfor; Theolbald Nji; Mathias Esum; Julious N Che; Armand Nkwescheu; Fifen Alassa; Geremy Kamnang; Peter A Enyong; Mark J Taylor; Achim Hoerauf; David W Taylor
Journal:  Parasit Vectors       Date:  2009-08-27       Impact factor: 3.876

5.  Loop-mediated isothermal amplification for rapid and semiquantitative detection of Loa loa infection.

Authors:  Papa M Drame; Doran L Fink; Joseph Kamgno; Jesica A Herrick; Thomas B Nutman
Journal:  J Clin Microbiol       Date:  2014-04-02       Impact factor: 5.948

Review 6.  Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda.

Authors:  Stefanie E O Meredith; Catherine Cross; Uche V Amazigo
Journal:  Health Res Policy Syst       Date:  2012-05-10

7.  Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon.

Authors:  Jean Paul Akue; Dieudonné Nkoghe; Cindy Padilla; Ghislain Moussavou; Hubert Moukana; Roger Antoine Mbou; Benjamin Ollomo; Eric Maurice Leroy
Journal:  PLoS Negl Trop Dis       Date:  2011-10-11

8.  The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA).

Authors:  Honorat Gustave Marie Zouré; Samuel Wanji; Mounkaïla Noma; Uche Veronica Amazigo; Peter J Diggle; Afework Hailemariam Tekle; Jan H F Remme
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28

9.  Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.

Authors:  Sébastien Ds Pion; Hugues Nana-Djeunga; Yannick Niamsi-Emalio; Cédric B Chesnais; Hugo Deléglise; Charles Mackenzie; Wilma Stolk; Daniel A Fletcher; Amy D Klion; Thomas B Nutman; Michel Boussinesq; Joseph Kamgno
Journal:  Lancet Infect Dis       Date:  2019-10-31       Impact factor: 25.071

Review 10.  Development of emodepside as a possible adulticidal treatment for human onchocerciasis-The fruit of a successful industrial-academic collaboration.

Authors:  Jürgen Krücken; Lindy Holden-Dye; Jennifer Keiser; Roger K Prichard; Simon Townson; Benjamin L Makepeace; Marc P Hübner; Steffen R Hahnel; Ivan Scandale; Achim Harder; Daniel Kulke
Journal:  PLoS Pathog       Date:  2021-07-22       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.